GeneDx Holdings Total Liabilities

GeneDx Holdings (SMFR) currently reports a total liabilities of $250M as of March 2026. That compares with $190M in the prior-year period — up 33.4% year over year. Use the charts on this page to explore GeneDx Holdings's total liabilities history and peer comparisons.

GeneDx Holdings's total liabilities increased from $190M to $250M — a 33.4% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GeneDx Holdings reported $250M in total liabilities as of March 2026. That compares with $190M in the prior-year period — up 33.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $250M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GeneDx Holdings, and consider following SMFR for alerts when major investors trade the stock.

GeneDx Holdings is classified in the Healthcare sector. On total liabilities, it currently shows $250M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SMFR with unrelated industries.